Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,921 | -1,145 | -4,255 | -22,727 | -10,276 |
| Depreciation Amortization | 1,084 | 721 | -720 | -1,569 | -1,848 |
| Income taxes - deferred | N/A | -313 | N/A | 831 | N/A |
| Accounts receivable | 1,356 | 927 | 203 | 592 | 425 |
| Other Working Capital | -311 | -1,047 | 761 | 604 | 254 |
| Other Operating Activity | -1,705 | -785 | -50 | 8,589 | 1,189 |
| Operating Cash Flow | $-1,497 | $-1,642 | $-4,061 | $-13,680 | $-10,256 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -135 | -85 | -2 | -11 | -57 |
| Other Investing Activity | 0 | 0 | 0 | -1 | 4 |
| Investing Cash Flow | $-135 | $-85 | $-2 | $-12 | $-53 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13 | 1 | N/A | N/A | N/A |
| Other Financing Activity | -205 | -134 | -38 | -118 | -101 |
| Financing Cash Flow | $-192 | $-133 | $-38 | $-118 | $-101 |
| Exchange Rate Effect | -2 | 208 | 50 | -879 | -1,074 |
| Beginning Cash Position | 10,190 | 10,190 | 50,611 | 65,300 | 65,300 |
| End Cash Position | 8,364 | 8,538 | 46,560 | 50,611 | 53,816 |
| Net Cash Flow | $-1,826 | $-1,652 | $-4,051 | $-14,689 | $-11,484 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,497 | -1,642 | -4,061 | -13,680 | -10,256 |
| Capital Expenditure | -135 | -85 | -2 | -11 | -57 |
| Free Cash Flow | -1,632 | -1,727 | -4,063 | -13,691 | -10,313 |